This document summarizes two projects - the EACH WOMAN Health project and a proposed synergy project on contraception and provider support.
The EACH WOMAN Health project aims to improve access to maternal and newborn healthcare in rural Tanzania through community consultations, mobile health data collection, and three interventions: village education meetings, transport vouchers, and birth kits with misoprostol. Initial results show barriers to facility access are understood but policy buy-in is challenging.
The synergy proposal would add a family planning component to also measure and improve contraceptive access and education through community health workers trained to provide services and referrals using mobile health applications. Collaboration is proposed with other groups to share
Economic Evaluation of the Electronic Palliative Care Coordination System (EP...NHS Improving Quality
As part of our work on End of Life Care, an Economic Evaluation of the Electronic Palliative Care Coordination System (EPaCCS) Early Implementer Sites was undertaken. The evaluation includes quantifying impact from implementation, co-ordination of care and the economic case for EPaCCS.
Peter Lubambi: Reducing Maternal Mortality with mHealth, MobileMonday Dar es ...Jukka Siltanen
Peter Lubambi from D-Tree International presented their initial finding and experiences on a mobile app designed to reduce maternal mortality.
Presentation available in YouTube:
http://www.youtube.com/watch?v=MWbEZ_HtlrA
HIV+ logbook tracks HIV + mother-baby pairs from pregnancy to 18 months post-partum
HIV- logbook tracks HIV- women through pregnancy for retesting at three months
The Joint Learning Network in Action: Spotlight on GhanaHFG Project
More and more countries are implementing complex health systems reforms to achieve universal health coverage. The Joint Learning Network (JLN) is a country-driven network of practitioners and policymakers who together develop knowledge products to bridge the gap between theory and practice, with the goal of extending health care coverage to more than 3 billion people.
The JLN community is comprised of leaders from ministries of health, national health financing agencies, and other key government institutions in 27 Asian, African, European, Latin American, and Middle Eastern countries as well as a diverse group of international, regional, and local partners.
On Thursday, September 22, the HFG Project hosted a technical briefing session on the JLN's work on the ground, and about Ghana’s National Health Insurance Authority (NHIA) on their collaboration with the JLN and the HFG project. Speakers included: Amanda Folsom (JLN Program Director, Results for Development), Nathaniel Otoo, (Chief Executive, Ghana NHIA), Dr. Lydia Dsane-Selby (Director, Claims, NHIA), and Chris Lovelace (Principal Associate, International Health, Abt Associates).
Nigeria national iccm implementation frameworktomowo George
The Nigeria's National ICCM implementation Framework is a 'one national iCCM Implementation Model' describing the activities expected to be carried out at the different levels of government, with clear programme boundaries, roles and responsibilities of individuals, organizations and other players. This framework also shows the pattern of information flow for iCCM in the country.
New frontiers: Linking family planning users to health facilities MEASURE Evaluation
Presented by Livia Montana, Measurement, Learning & Evaluation Project Carolina Population Center (UNC-CH), at the June 2012 MEASURE GIS Working Group meeting.
Overview of the Integrated Community Case Management (iCCM) of Childhood Illn...JSI
In a presentation at the Global Health Practitioner Conference, April 13-17, 2015, JSI's Dyness Kasungami (Maternal and Child Survival Program), provided an overview of the ICCM task force and subgroups involved in funding and implementing iCCM programs worldwide.
Interoperability, pop up uni, 10am, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Speaking at the 2015 CCIH Annual Conference, Juli Hedrick, MPH, Design and Development Officer, World Vision gives advice on how to strengthen health systems in post-conflict areas and other fragile contexts. She addresses issues such as human resources, the use of mobile technology and security.
Economic Evaluation of the Electronic Palliative Care Coordination System (EP...NHS Improving Quality
As part of our work on End of Life Care, an Economic Evaluation of the Electronic Palliative Care Coordination System (EPaCCS) Early Implementer Sites was undertaken. The evaluation includes quantifying impact from implementation, co-ordination of care and the economic case for EPaCCS.
Peter Lubambi: Reducing Maternal Mortality with mHealth, MobileMonday Dar es ...Jukka Siltanen
Peter Lubambi from D-Tree International presented their initial finding and experiences on a mobile app designed to reduce maternal mortality.
Presentation available in YouTube:
http://www.youtube.com/watch?v=MWbEZ_HtlrA
HIV+ logbook tracks HIV + mother-baby pairs from pregnancy to 18 months post-partum
HIV- logbook tracks HIV- women through pregnancy for retesting at three months
The Joint Learning Network in Action: Spotlight on GhanaHFG Project
More and more countries are implementing complex health systems reforms to achieve universal health coverage. The Joint Learning Network (JLN) is a country-driven network of practitioners and policymakers who together develop knowledge products to bridge the gap between theory and practice, with the goal of extending health care coverage to more than 3 billion people.
The JLN community is comprised of leaders from ministries of health, national health financing agencies, and other key government institutions in 27 Asian, African, European, Latin American, and Middle Eastern countries as well as a diverse group of international, regional, and local partners.
On Thursday, September 22, the HFG Project hosted a technical briefing session on the JLN's work on the ground, and about Ghana’s National Health Insurance Authority (NHIA) on their collaboration with the JLN and the HFG project. Speakers included: Amanda Folsom (JLN Program Director, Results for Development), Nathaniel Otoo, (Chief Executive, Ghana NHIA), Dr. Lydia Dsane-Selby (Director, Claims, NHIA), and Chris Lovelace (Principal Associate, International Health, Abt Associates).
Nigeria national iccm implementation frameworktomowo George
The Nigeria's National ICCM implementation Framework is a 'one national iCCM Implementation Model' describing the activities expected to be carried out at the different levels of government, with clear programme boundaries, roles and responsibilities of individuals, organizations and other players. This framework also shows the pattern of information flow for iCCM in the country.
New frontiers: Linking family planning users to health facilities MEASURE Evaluation
Presented by Livia Montana, Measurement, Learning & Evaluation Project Carolina Population Center (UNC-CH), at the June 2012 MEASURE GIS Working Group meeting.
Overview of the Integrated Community Case Management (iCCM) of Childhood Illn...JSI
In a presentation at the Global Health Practitioner Conference, April 13-17, 2015, JSI's Dyness Kasungami (Maternal and Child Survival Program), provided an overview of the ICCM task force and subgroups involved in funding and implementing iCCM programs worldwide.
Interoperability, pop up uni, 10am, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Speaking at the 2015 CCIH Annual Conference, Juli Hedrick, MPH, Design and Development Officer, World Vision gives advice on how to strengthen health systems in post-conflict areas and other fragile contexts. She addresses issues such as human resources, the use of mobile technology and security.
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Peri...Mohammad Aslam Shaiekh
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Perinatal Death Surveillance and Response (MPDSR) Program in MNH Section of Family Welfare Division
At the 2016 CCIH Annual Conference, Dr. Tonny Tumwesigye of the Uganda Protestant Medical Bureau discusses how UPMB incorporated fertility awareness methods into its Family Planning services to expand options for families.
Maternal and newborn health: some experiences and roles of the WCH Knowledge Hub in Asia and the Pacific
Chris Morgan
Principal Fellow, Centre for International Health
Burnet Institute
Jennifer Mason, Senior Advisor for FP/HIV Integration for USAID's Office of Population and Reproductive Health describes the agency's approach to integrating family planning services with HIV health services and provides country examples of integration practices.
CORE Group Fall Meeting 2010. WHO/UNICEF - Joint Statement Service Delivery & Program Implications, - Winnie Mwebesa & Stella Abwao, Save the Children.
In cooperation with the Research and Evaluation Division of BRAC, Copenhagen Consensus Center organized roundtable discussions with an aim to figure out smarter solutions to the most problematic issues facing Bangladesh.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Day 2 panel 2 building enhanced cadre tz 108026
1. Title of IMCHA Project: EACH WOMAN Health - “Enhancing all
Community Health Workers on Maternal and Newborn Health”
Title of Synergy Proposal: EWH Plus CAPS - “Contraception
and Provider Support”
Names of Implementation Research Team:
Dr. Bwire Chirangi (Tanzanian PI)
Dr. Gail Webber (Canadian co-PI)
DMO-RORYA and RMO-MARA
3. EACH WOMAN Health Overview
• Background
• high non-facility birth rate in Mara (about 60%)
• Barriers to accessing care are distances from facility, cost of transport and care, health care provider
attitudes, lack of supplies at facility, cultural and gender barriers
• Research Objectives
• Hold community and policy maker consultations to review barriers and solutions
• Conduct a multiple baseline trial focusing on using m-health applications to collect baseline data then
introducing 3 specific interventions to improve access to care: village meetings to educate about safe
deliveries, transport voucher for local motorcycle (boda boda) to access health facility at delivery, and
birth kits with misoprostol distribution to women to provide supplies for delivery (to be used for birth
in facility, but also outside of facility if women are unable or unwilling to access health care facility).
• Mixed Methods
• participatory action research for initial consultations
• m-health quantitative data on pregnancy registrations and use of interventions
• focus groups with women, CHWs and nurses on experiences
4. IMCHA Project Implementation
Results to Date/Key Lessons Learned
- Multiple barriers to facility access well understood by community members, but less so by policy makers
- Working with policy makers to encourage uptake is slow and requires building trust, very helpful to have DMO
staff in project and support from Regional and National level as well as NIMR
- Training CHWs to use m-health applications on smart phones requires large investment of training and ongoing
support
- Need for Close monitoring of m-health data and timely response to data collection problems
Challenges in Implementation and Mitigation Strategies
- Continue to work hard to involve DMO staff and promote buy-in, especially as DMO staff turns over, prepare for
end of project even as still rolling out project
- Invest more resources in CHW training and support, be selective about CHW chosen to work with project who is
capable of learning to use smart phone
- Regular communication between m-health consultants and research team to ensure quality data collection
5. IMCHA Project Implementation
Implementation Research Team – Focus on Capacity Strengthening
- Currently rolling out our multiple baseline intervention trial.
- Working on building capacity of CHWs to collect data using smart phones
-Preparing for 3 interventions (village meetings, transport vouchers and distribution
of birth kits with misoprostol)
Next Steps (Plan for 2017) and Areas for Collaboration
- Interventions to start in July 2017 in first division, then every 4 months thereafter to
remaining divisions
- Continue to have policy maker meetings every 6 months
- Collaboration with ECSA where possible, include other stakeholders
- Possible collaboration with other IMCHA teams, especially in Tanzania to promote
project findings and discuss means for sustainability
6. Synergy Proposal Overview
• Background
- in the Lake Zone rate of modern contraceptive use is only 15 % and the unmet need for contraception is 33 %, with
more frequent stock-outs of family planning items than elsewhere in Tanzania.
• Research Objectives
•To measure baseline use of family planning in rural Rorya District through m-health applications.
•To improve access to family planning and safe sex education and contraceptive methods.
•To train and support CHWs to provide family planning services using m-health applications for education and basic
methods (condoms and pills), and referral and reminders for advanced methods (injectable, implantable, IUDs and tubal
ligation).
•To train and support nurses to provide advanced methods in family planning to adolescents and women.
•To use m-health applications to monitor performance of CHWs and to help maintain stocks of family planning items in
rural health facilities in order to reduce stock outs.
•To regularly meet with community, District ,Regional and National policy makers for ongoing knowledge translation
activities.
• Mixed Methods
•m-health quantitative data on contraception use, stock monitoring and work flows of CHWs
•focus group data from women, CHWs, nurses and policy makers using PAR tools
7. Focus of Work in Synergy
Areas for Strategic Consideration/Collaboration
- Collaboration with ECSA, particularly for 6 monthly
policy maker meetings
- Presentations at other events in Tanzania (e.g.
national reproductive health task force meetings)
- Presentations at other academic and policy maker
events in Africa to share results